JP2025510791A5 - - Google Patents
Info
- Publication number
- JP2025510791A5 JP2025510791A5 JP2024556478A JP2024556478A JP2025510791A5 JP 2025510791 A5 JP2025510791 A5 JP 2025510791A5 JP 2024556478 A JP2024556478 A JP 2024556478A JP 2024556478 A JP2024556478 A JP 2024556478A JP 2025510791 A5 JP2025510791 A5 JP 2025510791A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263324003P | 2022-03-25 | 2022-03-25 | |
| US63/324,003 | 2022-03-25 | ||
| US202263417250P | 2022-10-18 | 2022-10-18 | |
| US63/417,250 | 2022-10-18 | ||
| US202363450607P | 2023-03-07 | 2023-03-07 | |
| US63/450,607 | 2023-03-07 | ||
| PCT/CA2023/050406 WO2023178452A1 (en) | 2022-03-25 | 2023-03-24 | Antibody-drug conjugates targeting folate receptor alpha and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025510791A JP2025510791A (ja) | 2025-04-15 |
| JP2025510791A5 true JP2025510791A5 (https=) | 2025-09-26 |
| JPWO2023178452A5 JPWO2023178452A5 (https=) | 2025-09-26 |
Family
ID=88099491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556478A Pending JP2025510791A (ja) | 2022-03-25 | 2023-03-24 | 葉酸受容体アルファを標的とする抗体－薬物コンジュゲート及び使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12433952B2 (https=) |
| EP (1) | EP4499698A1 (https=) |
| JP (1) | JP2025510791A (https=) |
| KR (1) | KR20240162575A (https=) |
| AU (1) | AU2023239448A1 (https=) |
| CA (1) | CA3245602A1 (https=) |
| CL (1) | CL2024002860A1 (https=) |
| CO (1) | CO2024012877A2 (https=) |
| IL (1) | IL315393A (https=) |
| MX (1) | MX2024011775A (https=) |
| WO (1) | WO2023178452A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4623936A1 (en) * | 2022-11-22 | 2025-10-01 | Keymed Biosciences (Chengdu) Co., Ltd. | Fused ring compound, conjugate thereof and use thereof |
| AU2024253122A1 (en) * | 2023-04-07 | 2025-10-23 | Innovent Biologics (Suzhou) Co., Ltd. | Antibody-drug conjugates of camptothecin derivatives and uses thereof |
| WO2024255740A1 (zh) * | 2023-06-13 | 2024-12-19 | 成都倍特药业股份有限公司 | 用于治疗或预防癌症的喜树碱衍生物及其抗体药物偶联物 |
| TW202530268A (zh) * | 2023-10-19 | 2025-08-01 | 加拿大商酵活英屬哥倫比亞有限公司 | 抗ｎａｐｉ２ｂ抗體－藥物結合物及使用方法 |
| WO2025106278A1 (en) | 2023-11-17 | 2025-05-22 | Mersana Therapeutics, Inc. | Treatment of cancer using b7-h4-targeted antibody-drug conjugates |
| WO2025235686A1 (en) * | 2024-05-07 | 2025-11-13 | Aarvik Therapeutics, Inc. | Fluorocamptothecin compounds, conjugates, and methods thereof |
| WO2026057740A1 (en) * | 2024-09-12 | 2026-03-19 | Astrazeneca Ab | Treatment of cancer with therapeutic binding molecules |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
| JP2002255821A (ja) | 2001-03-06 | 2002-09-11 | Yakult Honsha Co Ltd | 抗癌剤耐性癌に対する治療剤 |
| US7498298B2 (en) | 2003-11-06 | 2009-03-03 | Seattle Genetics, Inc. | Monomethylvaline compounds capable of conjugation to ligands |
| PL2635607T3 (pl) | 2010-11-05 | 2020-05-18 | Zymeworks Inc. | Projekt stabilnego przeciwciała heterodimerowego z mutacjami w domenie FC |
| CA2854233C (en) | 2011-11-04 | 2020-05-12 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the fc domain |
| AU2018237683A1 (en) * | 2017-03-24 | 2019-10-31 | Seagen Inc. | Process for the preparation of glucuronide drug-linkers and intermediates thereof |
| CA3094313A1 (en) | 2018-04-06 | 2019-10-10 | Seattle Genetics, Inc. | Camptothecin peptide conjugates |
| TWI851577B (zh) | 2018-06-07 | 2024-08-11 | 美商思進公司 | 喜樹鹼結合物 |
| HUE060364T2 (hu) | 2019-03-29 | 2023-02-28 | Medimmune Ltd | Vegyületek és konjugátumaik |
| JP7561141B2 (ja) | 2019-04-26 | 2024-10-03 | イミュノジェン・インコーポレーテッド | カンプトテシン誘導体 |
| CN110128501A (zh) * | 2019-05-21 | 2019-08-16 | 北京海美源医药科技有限公司 | 一种靶向fap酶的喜树碱类化合物及其制备方法和应用 |
| MX2021015887A (es) * | 2019-06-24 | 2022-03-22 | Hangzhou Dac Biotech Co Ltd | Un conjugado de un agente citotóxico y una molécula de unión a células con enlazadores ramificados. |
| CN115666642A (zh) * | 2020-05-11 | 2023-01-31 | 上毅生物科技股份有限公司 | 含有α-烯醇酶抗体的药物缀合物和其用途 |
| IL299001A (en) | 2020-06-19 | 2023-02-01 | Hangzhou Dac Biotech Co Ltd | Pairings of a cell-binding molecule with camptocin analogs |
| CN114569735A (zh) * | 2020-12-01 | 2022-06-03 | 泰州复旦张江药业有限公司 | 一种连接基-药物偶联物、制备方法及应用 |
| MX2023008895A (es) | 2021-02-09 | 2023-08-09 | Medilink Therapeutics Suzhou Co Ltd | Conjugado de sustancia bioactiva, metodo de preparacion y uso del mismo. |
| IL308734A (en) * | 2021-05-27 | 2024-01-01 | Zymeworks Bc Inc | Camptothecin analogues, conjugates and methods of use |
| CN117980327A (zh) | 2021-11-03 | 2024-05-03 | 杭州多禧生物科技有限公司 | 抗体的特异性偶联 |
| KR20240162569A (ko) | 2022-03-25 | 2024-11-15 | 자임워크스 비씨 인코포레이티드 | 항-엽산 수용체 알파 항체 및 사용 방법 |
-
2023
- 2023-03-24 IL IL315393A patent/IL315393A/en unknown
- 2023-03-24 JP JP2024556478A patent/JP2025510791A/ja active Pending
- 2023-03-24 CA CA3245602A patent/CA3245602A1/en active Pending
- 2023-03-24 KR KR1020247035390A patent/KR20240162575A/ko active Pending
- 2023-03-24 AU AU2023239448A patent/AU2023239448A1/en active Pending
- 2023-03-24 EP EP23773421.5A patent/EP4499698A1/en active Pending
- 2023-03-24 WO PCT/CA2023/050406 patent/WO2023178452A1/en not_active Ceased
-
2024
- 2024-05-29 US US18/677,564 patent/US12433952B2/en active Active
- 2024-09-24 CO CONC2024/0012877A patent/CO2024012877A2/es unknown
- 2024-09-25 MX MX2024011775A patent/MX2024011775A/es unknown
- 2024-09-25 CL CL2024002860A patent/CL2024002860A1/es unknown
-
2025
- 2025-06-24 US US19/247,831 patent/US20250339552A1/en active Pending